View the 250 Companies That Have Adopted Bionanotechnology in This Latest CDROM

Research and Markets (http://www.researchandmarkets.com/reports/c26560) has announced the addition of World Guide to Bionanotechnology Industry and its Progression, 2nd Edition to their offering.

Bionanotechnology will have a great impact on life science industries such as medical device, biotech equipment, diagnostic, and pharmaceuticals. The best way to learn about bionanotechnology in commercial applications is to study those who have adopted the technology. The author has in World Guide to Bionanotechnology Industry and its Progression outlined over 250 companies who have adopted bionanotechnology and gives you an insight to their technology platform, product development, collaborations and latest news.

The World Guide to Bionanotechnology Industry and its Progression product is based on a proprietary CD-ROM technology which includes smart database structure, find and sort options, internet and email interactivity. All companies are provided with links which connect you directly to the company webpage for further research. Both companies and pipeline projects can be further researched from inside the application by linking search queries directly to search engines like Google and PubMed. Found information on the CD-ROM may easily be shared with others over email or in print.

World Guide to Bionanotechnology Industry and its Progression is delivered to you as a CD-ROM product

Facts
Specific Information at Corporate Level
-More than 250 companies covered
-Nanotechnology platform descriptions
-Nano R&D pipeline projects
-Nano Partnerships
-News specific to nanotechnology development

Industry Segments with deployed Nanotechnology
-Biotechnology Equipment/Material
-CMO/CRO
-Diagnostics
-Enabling Technologies
-Medical Device
-Pharmaceutical/Therapeutics
-Service

Therapeutic Areas of Companies with Nanotechnology Platform
-Autoimmune/Inflammation
-Cancer
-Cardiovascular
-Dermatology
-Hematology
-Infectious diseases
-Metabolic diseases
-Neurological diseases
-Ophthalmic
-Pain
-Respiratory diseases

How May This Product Be of Use
-Find competitors, collaborations partners, M&A candidates etc.
-Jump start competitive intelligence operations
-Excellent starting point for world wide benchmarking
-Compare portfolio and therapy focus with your peers
-Speed up pro-active in-/outlicensing strategy work
-Track companies over time using search engines
-Track drugs over time using search engines
-Show investors/board/management that you are right on top of industry development

All Information is Delivered to You as a CD-ROM
-Smart CD-ROM database
-Multiple search and sort functions included
-Company and drug data is linked to search engines like Google and PubMed
-Directs you directly to corporate web pages from inside the application
-Found information is easily shared with others over email or in print
-Easy to use and navigate by

System Requirements
-AMD-Athlon/Pentium II PC
-Windows 98/NT4/2000/ME/XP
-8x-speed CD Rom drive
-SVGA 16 bit display. (32 bit recommended)
-32 MB of available RAM (128 MB recommended)
-Internet access (to test web-enabled presentations)

For more information visit http://www.researchandmarkets.com/reports/c26560

Laura Wood
Senior Manager
Research and Markets
email protected from spam bots
Fax: +353 1 4100 980




View the 250 Companies That Have Adopted Bionanotechnology in This Latest CDROM



***Note This page is an Archieve of Publicly released information either through our company or another Press Release organization. We do not "fact check", "Support", nor "Dispute" any of the information provided to us. We are a distribution point and Historical press release research and search service. This information only represents the fact that at one point in time the release was distributed to 1000's of publications both online and off. PRNewsNow will not take sides in any personal or commercial disputes you have with the writer of this press release. We will defend its right to exist blindly and without regards to its political, commercial or personal implications.***